ABCC1 and breast cancer: Li et al. [36] found that high expression of lncRNA GHET1 was related with the low sensitivity to gemcitabine of BC, lncRNA GHET1 contributed to chemotherapeutic resistance to gemcitabine in BC through upregulating ABCC1 expression.